• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

VIDEO: Safety of Group A Thawed Plasma for Trauma Patients

July 15, 2014

Today we will be discussing the safety of transfusing blood group A plasma to unidentified trauma patients. Group AB plasma, the universal plasma, does not contain anti-A or anti-B antibodies and is routinely given to trauma patients when their blood type is unknown. Group AB plasma, however, is in short supply.

Dr. Cooling elaborates:
“American Red Cross estimates only 2.5-2.6% of their active donors are going to be group AB. In addition, the use of AB plasma has skyrocketed over the last five years due in large part to the widespread adoption of massive transfusion protocols.”

The shortage of group AB plasma is also exacerbated by an AABB standard to mitigate TRALI risk.

Physicians at the UMass Memorial Medical Center hypothesized that group A plasma instead of AB plasma may be safely given to emergency trauma patients with an unknown blood type. Eighty-five percent of their patients are either group A or O, and incompatible plasma is already safely transfused with apheresis platelets. Out of 385 requests for emergency plasma over five years, 23 individuals received incompatible group A plasma transfusions—15 patients with group B blood and 8 with group AB blood.

Dr. Weinstein describes the major findings of the study:
“ It appears safe to give small numbers of plasma units of incompatible group A plasma. There were no adverse effects in the patients expressing the B allele who were either group B or group AB who received group A plasma and there was no evidence of hemolysis; there were no reported transfusion reactions.”

Additionally, two other smaller studies previously found similar results when using group A plasma for trauma patients.

Dr. Weinstein adds:
“Only 6% of our patients received group A plasma while the patient expresses the B allele. So I think other centers have to study this as well, and I think we need more data because presumably this will become a common practice but it would be better if it became a common practice based on high quality evidence.”

A large, multicenter trial likely needs to be implemented to confirm the safety of using group A plasma for trauma patients with unknown blood type.

We’ll be back with another edition of Transfusion News on August 30. Thanks for joining us.

Answer questions based on this video.

References

1. Chhibber V, Greene M, Vauthrin M, Bailey J, Weinstein R. Is group A thawed plasma suitable as the first option for emergency release transfusion? Transfusion 2014.
2. Cooling L. Going from A to B: The safety of incompatible group A plasma for emergency release in trauma and massive transfusion patients. Transfusion 2014(54):1695–1697.

Transfusion offers CME credit for this study! Log on at www.wileyhealthlearning.com/trf.
 

 

 

Filed Under

  • CME
  • Coagulation & Plasma Transfusion
  • Featured
  • Videos

Recommended

  • VIDEO: Reducing TRALI Risk

  • ABO Blood Group Alters Platelet Binding to von Willebrand Factor

  • Aspirin Increases Bleeding Risk

Show Comments

Reader Interactions

Comments

  1. mahammad safi says

    August 9, 2014 at 10:19 am

    yes it should be practiced where there are close monitoring systems….here in India if this will lead to anything..i mean anything

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley